These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16014068)

  • 41. Influence of convection on small molecule clearances in online hemodiafiltration.
    Ficheux A; Argilés A; Mion H; Mion CM
    Kidney Int; 2000 Apr; 57(4):1755-63. PubMed ID: 10760112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of pre-dilution and flushing on continuous renal replacement therapy.
    Koh KH
    Singapore Med J; 2006 Sep; 47(9):785-95. PubMed ID: 16924361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of pre- and postdilutional on-line hemodiafiltration adequacy by partial dialysate quantification and on-line urea monitor.
    Lim PS; Lee HP; Kho B; Yu YL; Chang SC; Lin YY; Yang CC; Wang TH; Kuo SY; Lin LC
    Blood Purif; 1999; 17(4):199-205. PubMed ID: 10494022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of residual function to removal of protein-bound solutes in hemodialysis.
    Marquez IO; Tambra S; Luo FY; Li Y; Plummer NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):290-6. PubMed ID: 21030575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clearance of quinupristin-dalfopristin (Synercid) and their main metabolites during continuous veno-venous hemofiltration (CVVH) with or without dialysis.
    Kim MK; Banevicius MA; Zhong M; Shi X; Hu M; Nightingale CH; Nicolau DP
    Int J Artif Organs; 2002 Jan; 25(1):33-9. PubMed ID: 11853069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous renal replacement therapy: does technique influence azotemic control?
    Morimatsu H; Uchino S; Bellomo R; Ronco C
    Ren Fail; 2002 Sep; 24(5):645-53. PubMed ID: 12380911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations.
    Morimatsu H; Uchino S; Bellomo R; Ronco C
    Int J Artif Organs; 2002 Jun; 25(6):512-9. PubMed ID: 12117290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Pharmacotherapy; 2000 Jun; 20(6):635-43. PubMed ID: 10853618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetics and dose of daily hemofiltration.
    Yamashita AC; Kawanishi H
    Blood Purif; 2004; 22 Suppl 2():14-9. PubMed ID: 15655317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urea removal by hemofiltration and hemodiafiltration.
    Gouyon JB; Petion AM; Huet F; Lallemant C
    Biol Neonate; 1994; 65(1):36-40. PubMed ID: 8117843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Creatinine and urea clearance during continuous veno-venous haemofiltration in critically ill patients.
    Brocklehurst IC; Thomas AN; Kishen R; Guy JM
    Anaesthesia; 1996 Jun; 51(6):551-3. PubMed ID: 8694207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automatic continuous venovenous hemodiafiltration in cardiosurgical patients.
    Caprioli R; Favilla G; Palmarini D; Comite C; Gemignani R; Rindi P; Cioni L
    ASAIO J; 1993; 39(3):M606-8. PubMed ID: 8268609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system.
    Jeffrey RF; Khan AA; Prabhu P; Todd N; Goutcher E; Will EJ; Davison AM
    Artif Organs; 1994 Jun; 18(6):425-8. PubMed ID: 8060251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).
    Vos MC; Vincent HH; Yzerman EP
    Intensive Care Med; 1992; 18(5):282-5. PubMed ID: 1527259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Continuous venovenous hemodiafiltration in critically ill patients with acute renal failure].
    Toft P; Felding M; Tønnesen EK
    Ugeskr Laeger; 2000 May; 162(20):2868-71. PubMed ID: 10860424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective study of continuous venovenous hemodiafiltration in critically ill patients with acute renal failure.
    Bellomo R; Farmer M; Boyce N
    J Intensive Care Med; 1995; 10(4):187-92. PubMed ID: 10155183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.